Vineet Laboratories Limited

Vineet Laboratories Limited (VINEETLAB) is a micro-cap Healthcare company valued at ₹75 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Vineet Laboratories Limited last traded at ₹38.8, modestly up 0.57% on the day.

Recent developments

On 2026-06-30, foreign institutional holding increased by 0.14 percentage points to 0.50%, suggesting some foreign investors may be adding to their positions. The company's latest quarter results show a significant turnaround, with net profit turning positive for the first time in over a year.

Financial performance

The company's business has declined over the past five years, with revenue falling at -20.8% annually and profit dropping at -24.8% annually. However, the latest quarter saw revenue rise 34.2% compared to the same quarter a year earlier, and net profit swung from a loss of ₹11 crore to a profit of ₹1 crore.

Valuation multiples

The stock trades at 66.9 times earnings, a premium to the Healthcare median of 32.0, 1.55 times book value. It yields 2.8%.

Things to watch

The company's net profit margin remains low at 2.7%, and return on equity is weak at 3.5%. The stock is 28.2% below its 52-week high, and the company's revenue has declined for five consecutive years, with a 3-year annualized decline of -26.7%.

Where it stands

Vineet Laboratories Ltd ended the latest quarter with a net profit of ₹1 crore, marking a reversal from a net loss a year earlier. The stock is 28.2% below its 52-week high, and the company's revenue has declined for five years, with a 3-year annualized drop of -26.7%.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.